These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10573532)
1. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Pessoa MG; Bzowej N; Berenguer M; Phung Y; Kim M; Ferrell L; Hassoba H; Wright TL Hepatology; 1999 Dec; 30(6):1513-20. PubMed ID: 10573532 [TBL] [Abstract][Full Text] [Related]
2. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications. Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936 [TBL] [Abstract][Full Text] [Related]
3. Virology and pathogenesis of hepatitis C virus recurrence. Ramírez S; Pérez-Del-Pulgar S; Forns X Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723 [TBL] [Abstract][Full Text] [Related]
4. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Pelletier SJ; Raymond DP; Crabtree TD; Iezzoni JC; Sawyer RG; Hahn YS; Pruett TL Hepatology; 2000 Aug; 32(2):375-81. PubMed ID: 10915745 [TBL] [Abstract][Full Text] [Related]
5. Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation. Schramm F; Soulier E; Royer C; Weitten T; Fafi-Kremer S; Brignon N; Meyer N; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Doffoël M; Baumert TF; Stoll-Keller F; Schvoerer E J Infect Dis; 2008 Dec; 198(11):1656-66. PubMed ID: 18925843 [TBL] [Abstract][Full Text] [Related]
6. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Feliu A; Gay E; García-Retortillo M; Saiz JC; Forns X Liver Transpl; 2004 Sep; 10(9):1131-9. PubMed ID: 15350003 [TBL] [Abstract][Full Text] [Related]
7. Sequence variation in the hypervariable region 1 of hepatitis C virus and posttransplantation recurrent hepatitis. Silini E; Belli L; Brambilla S; Foti L; Gritti C; Lisa A; Alberti AB; Vinci M; De Carlis L; Rondinara G; Pinzello G Liver Transpl; 2003 Oct; 9(10):1040-7. PubMed ID: 14526398 [TBL] [Abstract][Full Text] [Related]
8. Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis. Kamar N; Rostaing L; Boulestin A; Sandres K; Dubois M; Ribes D; Modesto A; Durand D; Izopet J J Med Virol; 2003 Apr; 69(4):482-8. PubMed ID: 12601755 [TBL] [Abstract][Full Text] [Related]
9. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression. Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J J Hepatol; 2006 Apr; 44(4):717-22. PubMed ID: 16487616 [TBL] [Abstract][Full Text] [Related]
10. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation. Hughes MG; Rudy CK; Chong TW; Smith RL; Evans HL; Iezzoni JC; Sawyer RG; Pruett TL Liver Transpl; 2004 Feb; 10(2):208-16. PubMed ID: 14762858 [TBL] [Abstract][Full Text] [Related]
11. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. Schvoerer E; Soulier E; Royer C; Renaudin AC; Thumann C; Fafi-Kremer S; Brignon N; Doridot S; Meyer N; Pinson P; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Zachary P; Baumert T; Stoll-Keller F J Infect Dis; 2007 Aug; 196(4):528-36. PubMed ID: 17624837 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Lawal Z; Petrik J; Wong VS; Alexander GJ; Allain JP Virology; 1997 Feb; 228(1):107-11. PubMed ID: 9024815 [TBL] [Abstract][Full Text] [Related]
13. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065 [TBL] [Abstract][Full Text] [Related]
14. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients. Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Sherman KE; Rouster SD; Mendenhall C; Thee D Hepatology; 1999 Jul; 30(1):265-70. PubMed ID: 10385665 [TBL] [Abstract][Full Text] [Related]
17. Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Berenguer M Liver Transpl; 2003 Nov; 9(11):S44-7. PubMed ID: 14586894 [TBL] [Abstract][Full Text] [Related]
18. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875 [TBL] [Abstract][Full Text] [Related]
19. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. Maggi F; Fornai C; Morrica A; Vatteroni ML; Giorgi M; Marchi S; Ciccorossi P; Bendinelli M; Pistello M J Med Virol; 1999 Jan; 57(1):57-63. PubMed ID: 9890422 [TBL] [Abstract][Full Text] [Related]